Sign In
Buy COWN
$38.99
+0 (+0%)
At Close: May 26, 2023
Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference
08:00am, Monday, 24'th Feb 2025
MORRISTOWN, N.J. , Feb. 24, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI) announced today its presentation at the TD Cowen 45th Annual Healthcare Conference, taking place March 3-5, 2
Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference
07:30am, Monday, 24'th Feb 2025
NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative t
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
07:00am, Monday, 24'th Feb 2025
WALTHAM, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the TD Cowen 45th Annual Health Care Conference on Mond
Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
07:00am, Monday, 24'th Feb 2025
BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today ann
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
06:59am, Monday, 24'th Feb 2025
CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what's possible for people living with T cell-driven autoimmune diseases
Merck to Participate in the TD Cowen 45th Annual Health Care Conference
06:45am, Monday, 24'th Feb 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the TD Cowen 45th Annual Health Care Conference.
agilon health to Participate in TD Cowen's 45th Annual Health Care Conference
04:00pm, Friday, 21'st Feb 2025
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 45th An
Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference
08:30am, Friday, 21'st Feb 2025
SALT LAKE CITY , Feb. 21, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy bi
Butterfly Network to Participate at the TD Cowen 45th Annual Health Care Conference on March 3, 2025
08:05am, Friday, 21'st Feb 2025
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound a
Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference
08:00am, Friday, 21'st Feb 2025
CONSHOHOCKEN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the 45th Annual TD Cowen Health Care Conference
BioAge Labs to Participate in TD Cowen's 45th Annual Health Care Conference
04:30pm, Thursday, 20'th Feb 2025
RICHMOND, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates f
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
04:15pm, Thursday, 20'th Feb 2025
DUBLIN , Feb. 20, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in TD Cowen's 45th Annual Health Care Conference. Company management w
Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
04:05pm, Thursday, 20'th Feb 2025
MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced p
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
04:05pm, Thursday, 20'th Feb 2025
SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therap
IO Biotech to Present at the 45th Annual Cowen Health Care Conference
08:05am, Thursday, 20'th Feb 2025
Presentation will include an update on the development and launch preparations of Cylembio™ (imsapepimut and etimupepimut, adjuvanted) NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq:
